|
1 |
Is there really an accelerated phase of chronic myeloid leukaemia?
Enthalten in Leukemia 25.6.2024: 1-2
|
|
|
|
2 |
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy
Enthalten in Leukemia 8.3.2024: 1-4
|
|
|
|
3 |
Response to “Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions” by Heidel et al
Enthalten in Leukemia 28.9.2018: 1-2
|
|
|
|
4 |
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes
Enthalten in Experimental hematology & oncology Bd. 5, 27.4.2016, Nr. 1, date:12.2015: 1-8
|
|
|
|
5 |
Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?
Enthalten in Leukemia Bd. 37, 20.7.2023, Nr. 10, date:10.2023: 1963-1968
|
|
|
|
6 |
Can Immune Therapy Cure Acute Myeloid Leukemia?
Enthalten in Current treatment options in oncology Bd. 24, 22.3.2023, Nr. 5, date:5.2023: 381-386
|
|
|
|
7 |
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma
Enthalten in Blood cancer journal Bd. 13, 5.9.2023, Nr. 1, date:12.2023: 1-4
|
|
|
|
8 |
Challenges determining the best target duration of deep molecular response after which to attempt achieving therapy-free remission in chronic myeloid leukaemia
Enthalten in Leukemia Bd. 39, 25.2.2025, Nr. 4, date:4.2025: 810-815
|
|
|
|
9 |
Changing causes of death in persons with haematological cancers 1975–2016
Enthalten in Leukemia Bd. 36, 16.5.2022, Nr. 7, date:7.2022: 1850-1860
|
|
|
|
10 |
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms
Enthalten in Leukemia Bd. 36, 12.10.2022, Nr. 12, date:12.2022: 2875-2882
|
|
Administration
